PRESS RELEASE published on 08/13/2024 at 07:00, 1 year 11 months ago Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 PolyPeptide Group AG reports solid progress in H1 2024 with upgraded full-year guidance and mid-term target to double 2023 revenue by 2028. Revenue growth driven by commercial activities and operational improvements Revenue Growth PolyPeptide Group AG Full-year Guidance H1 2024 Mid-term Target
BRIEF published on 08/08/2024 at 20:05, 2 years ago PolyPeptide nomme un directeur commercial PolyPeptide Directeur Commercial Stéphane Varray Ingrédients Pharmaceutiques Thérapies GLP-1
BRIEF published on 08/08/2024 at 20:05, 2 years ago PolyPeptide appoints Chief Commercial Officer Chief Commercial Officer PolyPeptide Stéphane Varray Pharmaceutical Ingredients GLP-1 Therapies
PRESS RELEASE published on 08/08/2024 at 20:00, 2 years ago PolyPeptide appoints Chief Commercial Officer PolyPeptide Group AG announces the appointment of Stéphane Varray as Chief Commercial Officer and member of the Management Committee, effective January 2025 Growth Strategy Pharmaceuticals Chief Commercial Officer PolyPeptide Stéphane Varray
BRIEF published on 04/10/2024 at 19:28, 2 years 4 months ago PolyPeptide annonce des résultats positifs lors de l'assemblée générale annuelle 2024 Gouvernance D'Entreprise Approbation Des Actionnaires Assemblée Générale Annuelle 2024 Groupe Polypeptide États Financiers 2023
BRIEF published on 04/10/2024 at 19:28, 2 years 4 months ago PolyPeptide Announces Positive Outcomes at 2024 Annual General Meeting Shareholder Approval Corporate Governance Annual General Meeting 2024 PolyPeptide Group Financial Statements 2023
PRESS RELEASE published on 04/10/2024 at 19:23, 2 years 4 months ago PolyPeptide announces results of the annual General Meeting 2024 PolyPeptide Group AG announces successful approval of all proposals at annual General Meeting 2024. Details include re-election of Board members and approval of key financial matters Board Of Directors Annual General Meeting Shareholders PolyPeptide Group AG Financial Approvals
BRIEF published on 03/19/2024 at 07:05, 2 years 4 months ago PolyPeptide Group annonce son assemblée générale annuelle 2024 Conseil D'administration Gouvernance D'Entreprise Assemblée Générale Annuelle Groupe Polypeptide Industrie Pharmaceutique
BRIEF published on 03/19/2024 at 07:05, 2 years 4 months ago PolyPeptide Group Announces Annual General Meeting 2024 Board Of Directors Annual General Meeting Pharmaceutical Industry Corporate Governance PolyPeptide Group
PRESS RELEASE published on 03/19/2024 at 07:00, 2 years 4 months ago PolyPeptide publishes invitation to the annual General Meeting 2024 PolyPeptide Group AG publishes invitation to the annual General Meeting 2024 with details of proposed agenda items and changes to the Board of Directors Board Of Directors Annual General Meeting 2024 AGM 2024 PolyPeptide Group AG Remuneration Committee
Published on 08/11/2026 at 14:30, 2 hours 20 minutes ago ACCESS Newswire Reports Second Quarter 2026 Results
Published on 08/11/2026 at 14:30, 2 hours 20 minutes ago AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
Published on 08/11/2026 at 14:00, 2 hours 50 minutes ago First Canadian Graphite Signs Agreement with Groupe Nipi, in Collaboration with BBA, for its Preliminary Environmental Study at Lac Guéret Sud
Published on 08/11/2026 at 14:00, 2 hours 50 minutes ago First Canadian Graphite conclut une entente avec le Groupe Nipi en collaboration avec la firme BBA pour une étude environnementale préliminaire au Lac Guéret Sud
Published on 08/11/2026 at 13:30, 3 hours 20 minutes ago Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 15:57, 53 minutes ago Medios Acquires a 74% Majority Stake in Caelo and Strengthens Its German and European Business in Active Pharmaceutical Ingredients and Excipients
Published on 08/10/2026 at 18:00, 22 hours 50 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 22 hours 50 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 23 hours 5 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day 4 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
